Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

Share Price Information for 1Spatial Holdings (SPA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 63.00
Bid: 61.00
Ask: 65.00
Change: 0.00 (0.00%)
Spread: 4.00 (6.557%)
Open: 63.00
High: 63.00
Low: 63.00
Prev. Close: 63.00
SPA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of Scheme Document

12 Mar 2010 11:22

RNS Number : 5050I
Xploite PLC
12 March 2010
 



Not for release, publication or distribution, in whole or in part, in, directly or indirectly, or into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction

 

12 March 2010

 

Recommended proposal for the acquisition of Xploite plc ("Xploite") by Avisen plc

("Avisen") to be implemented by means of a Scheme of Arrangement

 

POSTING OF SCHEME DOCUMENT

 

On 11 March 2010, the directors of Xploite and Avisen announced that they had reached agreement on the terms of a recommended Proposal under which Avisen will acquire the entire issued and to be issued share capital of Xploite, to be implemented by means of a scheme of arrangement (the "Scheme") under Part 26 of the Companies Act 2006 (the "Act").

 

Capitalised terms used in this announcement shall have the same meaning as ascribed in the announcement dated 11 March 2010 unless the context otherwise requires.

 

The board of Xploite is pleased to announce that the scheme document (the "Scheme Document") containing, inter alia, the terms and conditions of the Scheme, an explanatory statement (in compliance with section 897 of the Act), notices of the Court Meeting and General Meeting of Xploite, a timetable of principal events, and details of the actions to be taken by Xploite Shareholders is today being posted to all Xploite Shareholders.

 

As described in the Scheme Document, the Scheme and the Proposal are subject to the satisfaction (or, where applicable, waiver) of the Conditions set out in Part IV of the Scheme Document. In addition, the implementation of the Scheme will require approval by a special resolution of Xploite Shareholders to be proposed at the General Meeting. In order to become effective, the Scheme must be approved by Scheme Shareholders at the Court Meeting (at which voting will be conducted by way of a poll). The approval required at the Court Meeting is a majority in number of those Scheme Shareholders present and voting, whether in person or by proxy, representing not less than 75 per cent. in value of the Scheme Shares held by such Scheme Shareholders.

 

The expected timetable of principal events is *:

 

Event

Time and/or date 1

Latest time for lodging BLUE Forms of Proxy for the Court Meeting 2

 

11.00 a.m. 4 April 2010

 

Latest time for lodging WHITE Forms of Proxy for the General Meeting

 

11.15 a.m. 4 April 2010

 

Voting Record Time for the Meetings 3

 

6.00 p.m. 4 April 2010

 

Avisen General Meeting

 

10.00 a.m. on 6 April 2010

 

Court Meeting

 

11.00 a.m. 6 April 2010

 

General Meeting 4

 

11.15 a.m. 6 April 2010

 

Last day of dealings in and registration of transfers in CREST of Xploite Shares

 

12 April 2010

 

Disablement in CREST of Xploite Shares

 

7.00 a.m. 13 April 2010

 

Xploite Shares suspended

 

7.00 a.m. 13 April 2010

 

Scheme Court Hearing

 

13 April 2010

 

Scheme Record Time

 

6.00 p.m. 14 April 2010

 

Reduction Court Hearing

 

15 April 2010

 

Effective Date of the Scheme

 

15 April 2010

 

Cancellation of admission of Xploite Shares on AIM

 

7.00 a.m. 16 April 2010

 

Admission of the New Avisen Shares to trading on AIM

 

8.00 a.m. 16 April 2010

 

Crediting of New Avisen Shares to CREST accounts

 

16 April 2010

 

Latest date for despatch of the share certificates of the New Avisen Shares to be issued to Xploite Shareholders

 

29 April 2010

 

* Please note that certain dates have changed since the announcement on 11 March 2010.

 

1. The dates and times above are indicative only and will depend, inter alia, on the date on which: (i) the Conditions are either satisfied or waived (to the extent they are capable of being waived); (ii) the Court sanctions the Scheme and confirms the associated Reduction of Capital; and (iii) the Reduction of Capital is registered by the Registrar of Companies in England and Wales. If any of the expected dates change, Xploite will give adequate notice of any change by issuing an announcement through a Regulatory Information Service.

 

2. If any of the Meetings are adjourned by more than 48 hours, then the Voting Record Time for the reconvened Meeting will be 6.00 p.m. on the day which is two days before such reconvened Meeting.

 

3. The BLUE Form of Proxy for the Court Meeting may alternatively be handed to Xploite's Registrars on behalf of the Chairman of the Court Meeting at the start of the Court Meeting.

 

4. If the Court Meeting has not been concluded or adjourned prior to the scheduled commencement of the General Meeting, the commencement of the General Meeting will be delayed until the Court Meeting has been concluded or adjourned.

 

In accordance with Rule 19.11 of the City Code, a copy of this announcement and the Scheme Document will be published on Xploite's website at www.xploite.co.uk and Avisen's website at www.avisenplc.com and copies of the Scheme Document and Forms of Proxy will be available from the offices of Beachcroft LLP, 100 Fetter Lane, London EC4A 1BN.

 

Enquiries:

 

Xploite plc

0870 737 2001

Ian Smith (Chief Executive Officer)

Robert Arrowsmith (Chief Financial Officer)

Brewin Dolphin Investment Banking (financial adviser to Xploite)

0845 213 1000

Matt Davis

Neil McDonald

Hansard Communications (PR adviser to Xploite)

020 7245 1100

Justine James

Adam Reynolds

Avisen plc

0870 880 2978

Marcus Hanke (Chief Executive Officer)

Zeus Capital Limited (financial adviser to Avisen)

0161 831 1512

Ross Andrews

Nick Cowles

Bishopsgate Communications (PR adviser to Avisen)

020 7562 3355

Robyn Samuelson

Siobhra Murphy

Brewin Dolphin Investment Banking, a division of Brewin Dolphin Limited, which is authorised and regulated by the Financial Services Authority in the United Kingdom, is acting for Xploite and no one else in relation to the offer and will not be responsible to anyone other than Xploite for providing the protections afforded to clients of Brewin Dolphin Limited nor for providing advice in relation to the contents of the Announcement or any offer or arrangement referred to herein.

 

Zeus Capital Limited, which is authorised and regulated by the Financial Services Authority in the United Kingdom, is acting for Avisen and no one else in relation to the offer and will not be responsible to anyone other than Avisen for providing the protections afforded to clients of Zeus Capital Limited nor for providing advice in relation to the contents of the Announcement or any offer or arrangement referred to herein.

 

The distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe, any applicable requirements. Any failure to comply with the restrictions may constitute a violation of the securities laws of any such jurisdiction. This announcement does not constitute an offer or an invitation to purchase or subscribe for any securities or a solicitation of an offer to buy any securities pursuant to this announcement or otherwise in any jurisdiction in which such offer or solicitation is unlawful. This announcement has been prepared for the purposes of complying with English law, the Code and the AIM Rules and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of any jurisdiction outside England.

 

Dealing Disclosure Requirements

 

Under the provisions of Rule 8.3 of the Code, if any person is, or becomes, "interested" (directly or indirectly) in one per cent. or more of any class of "relevant securities" of Xploite or Avisen, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant transaction. This requirement will continue until the date on which the Scheme becomes Effective, (or, if implemented by way of an offer, the offer becomes, or is declared, unconditional as to acceptances, lapses) or otherwise lapses or is withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Xploite or Avisen, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Xploite or Avisen by Avisen or Xploite, or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the Business Day following the date of the relevant transaction.

 

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

 

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ODPMMGMFMZRGGZM
Date   Source Headline
24th Apr 20247:00 amRNSFinal Results
9th Apr 20247:00 amRNSNotice of Results Presentations
14th Mar 20247:00 amRNSDirector Share Purchase & PDMR Dealing
13th Mar 202410:09 amRNSDirector Share Purchase & PDMR Dealing
13th Mar 20247:00 amRNSEmployee Share Awards and PDMR Dealings
12th Mar 20247:00 amRNS1Streetworks Investor Seminar
11th Mar 20247:00 amRNSTrading Update and Notice of Results
22nd Feb 20247:00 amRNSUK Power Networks selects 1Streetworks software
13th Feb 20241:31 pmRNSNotification of Major Holdings
30th Jan 20247:00 amRNSNew customer multi-year contract
10th Jan 20247:00 amRNSEnterprise contract wins
9th Jan 20243:27 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSExercise of Options and Total Voting Rights
27th Nov 20235:15 pmRNSNew digital map expected to grow economy - amended
27th Nov 20237:00 amRNSNew digital map expected to grow economy by £5bn
22nd Nov 20233:11 pmRNSExercise of Options & Total Voting Rights
25th Oct 20231:15 pmRNSHolding(s) in Company
10th Oct 20237:00 amRNSInterim Results
19th Sep 20237:00 amRNSNotice of Results & Investor Presentations
7th Jul 20233:48 pmRNSResults of Annual General Meeting
7th Jul 20237:00 amRNSAGM Statement and Trading Update
3rd Jul 20237:00 amRNSTotal Voting Rights
19th Jun 20237:00 amRNSFirst Two TMPA Contracts
25th May 20237:00 amRNSReport and Accounts and Notice of AGM
28th Apr 20237:00 amRNSDirector Share Purchase & PDMR Dealing
26th Apr 20237:00 amRNSFinal Results
11th Apr 20237:00 amRNSNotice of Analyst and Investor Presentations
31st Mar 20235:03 pmRNSSatisfaction of Deferred Consideration & TVR
14th Mar 20234:01 pmRNSTR-1: Notification of Major Holdings
6th Mar 20237:00 amRNSTrading Update and Notice of Results
18th Jan 20233:07 pmRNSExercise of Options and Total Voting Rights
15th Dec 20227:00 amRNSDirectorate Change
2nd Nov 20227:00 amRNSDirector Share Purchase & PDMR Dealing
28th Oct 20221:51 pmRNSExercise of Options
28th Sep 20227:00 amRNSInterim results
5th Sep 20227:00 amRNSTwo significant US contract wins
26th Aug 20227:00 amRNSNotice of Results and Investor Presentation
27th Jul 202211:46 amRNSDirector Share Purchases & PDMR Dealings
19th Jul 20227:00 amRNSContract with European aerospace company
11th Jul 20227:00 amRNSContract win
21st Jun 202212:15 pmRNSResult of AGM
21st Jun 20227:00 amRNSAGM Statement and Trading Update
20th Jun 202212:35 pmRNSHolding(s) in Company
8th Jun 20227:00 amRNSFirst significant contract with High Speed Two
23rd May 20227:00 amRNSFirst contract with the State of New York
18th May 20224:47 pmRNSReport and Accounts and Notice of AGM
16th May 20227:00 amRNSAttendance at the Mello Investor Conference
11th May 20227:00 amRNS$1.4m expansion contract with State of California
27th Apr 20227:00 amRNSFinal Results
6th Apr 20229:30 amRNSNotice of Results and Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.